IR@PKUHSC  > 北京大学第一临床医学院  > 心血管内科
学科主题临床医学
Folic acid supplementation with and without vitamin B6 and revascularization risk: A meta-analysis of randomized controlled trials
Qin, Xianhui1,2; Fan, Fangfang3; Cui, Yimin4; Chen, Fang5; Chen, Yundai6; Cheng, Xiaoshu7; Li, Yuming8,9; Wang, Binyan1; Xu, Xin10; Xu, Xiping10; Huo, Yong3; Wang, Xiaobin11
关键词Folic Acid Supplementation Revascularization Risk Randomized Controlled Trials Meta-analysis
刊名CLINICAL NUTRITION
2014-08-01
DOI10.1016/j.clnu.2014.01.006
33期:4页:603-612
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Nutrition & Dietetics
研究领域[WOS]Nutrition & Dietetics
关键词[WOS]HOMOCYSTEINE-LOWERING THERAPY ; STAGE RENAL-DISEASE ; PERCUTANEOUS CORONARY INTERVENTION ; ACUTE MYOCARDIAL-INFARCTION ; CARDIOVASCULAR-DISEASE ; B-VITAMINS ; STROKE PREVENTION ; SECONDARY PREVENTION ; VASCULAR-DISEASE ; TOTAL MORTALITY
英文摘要

Background & aims: There is a growing amount of data and a continuing controversy over the effect of folic acid supplementation with and without vitamin B6 on revascularization risk.

Methods: We conducted a meta-analysis based on up-to-date published relevant randomized trials to further examine this issue. Relative risk (RR) was used to measure the effect of folic acid supplementation on risk of revascularization using a random-effects model. Total revascularization was defined as any arterial revascularization. Restenosis was defined as stenosis of more than 50 percent of the luminal diameter.

Results: Overall, folic acid supplementation had no significant effect on coronary revascularization (9 trials, n = 27,418, RR = 0.99; 95%CI:0.88-1.11, P = 0.88), coronary artery bypass grafting (CABG) (5 trials, n = 10,703, 0.90; 0.79-1.03, P = 0.11), percutaneous coronary intervention (PCI) (5 trials, n = 10,703, 1.05; 0.89-1.23, P = 0.59), coronary restenosis (3 trials, n = 926, 1.05; 0.89-1.23, P = 0.59) or total revascularization (7 trials, n = 29,314, 1.06; 95%CI: 0.99-1.13, P = 0.10). However, a greater beneficial effect was observed for coronary revascularization among those trials with a moderate dose of vitamin B6 (5-10 mg/d; RR: 0.47; 95%CI: 0.28-0.80, P = 0.005), but not in trials without vitamin B6 or with a high dose of vitamin B6. And a non-significant greater total revascularization risk was observed in trials with a higher folic acid dose (>2 mg/d, RR = 1.11; 95%CI: 0.98-1.25, P = 0.09; >= 5 mg/d, RR = 1.98; 95%CI: 0.93-4.20, P = 0.08).

Conclusions: Our analyses indicate that folic acid supplementation has no significant effect on coronary revascularization, CABG, PCI, coronary restenosis or total revascularization. However, a combination of folic acid and moderate vitamin B6 may be beneficial in reducing coronary revascularization risk. (C) 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

语种英语
WOS记录号WOS:000338810300006
项目编号2012CB517703 ; 2012zx09101-105
资助机构Major State Basic Research Development Program of China (973 program) ; Ministry of Science and Technology of the People&prime ; s Republic of China
引用统计
被引频次:6[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/52200
专题北京大学第一临床医学院_心血管内科
作者单位1.Anhui Med Univ, Inst Biomed, Hefei, Peoples R China
2.Peking Univ, Hosp 1, Dept Pharm, Beijing 100871, Peoples R China
3.Southern Med Univ, Nanfang Hosp, Div Nephrol, Guangzhou, Guangdong, Peoples R China
4.Peking Univ, Hosp 1, Dept Cardiol, Beijing 100871, Peoples R China
5.Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China
6.Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing, Peoples R China
7.Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Peoples R China
8.Chinese Peoples Armed Police Forces, Inst Cardiovasc Dis, Tianjin, Peoples R China
9.Chinese Peoples Armed Police Forces, Ctr Heart, Pinjing Hosp Logist Univ, Tianjin, Peoples R China
10.Southern Med Univ, Guangdong Inst Nephrol, Guangzhou, Guangdong, Peoples R China
11.Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Early Life Origins Dis, Dept Populat Family & Reprod Hlth, Baltimore, MD USA
推荐引用方式
GB/T 7714
Qin, Xianhui,Fan, Fangfang,Cui, Yimin,et al. Folic acid supplementation with and without vitamin B6 and revascularization risk: A meta-analysis of randomized controlled trials[J]. CLINICAL NUTRITION,2014,33(4):603-612.
APA Qin, Xianhui.,Fan, Fangfang.,Cui, Yimin.,Chen, Fang.,Chen, Yundai.,...&Wang, Xiaobin.(2014).Folic acid supplementation with and without vitamin B6 and revascularization risk: A meta-analysis of randomized controlled trials.CLINICAL NUTRITION,33(4),603-612.
MLA Qin, Xianhui,et al."Folic acid supplementation with and without vitamin B6 and revascularization risk: A meta-analysis of randomized controlled trials".CLINICAL NUTRITION 33.4(2014):603-612.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Qin, Xianhui]的文章
[Fan, Fangfang]的文章
[Cui, Yimin]的文章
百度学术
百度学术中相似的文章
[Qin, Xianhui]的文章
[Fan, Fangfang]的文章
[Cui, Yimin]的文章
必应学术
必应学术中相似的文章
[Qin, Xianhui]的文章
[Fan, Fangfang]的文章
[Cui, Yimin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。